SM
CHTP

Sabby Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Sabby Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-83,200
Closed -$369K – 311
2013
Q4 		$369K Buy
+83,200
New +$281K 0.02% 161

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's CHTP Position: Q1 2014 in Review

Sabby Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 83,200 shares — an estimated $369K sold.

Sabby Management first reported a position in CHTP in Q4 2013 and held it in 1 quarter. The position peaked at $369K in Q4 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • Sabby Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • Sabby Management sold 83,200 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $369K.
  • Sabby Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 1 quarter.
  • Sabby Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $369K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Sabby Management's 13F filing for Q1 2014, filed 14 May 2014.